We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
TolerRx Announces Manufacturing and Supply Agreement with Abbott
News

TolerRx Announces Manufacturing and Supply Agreement with Abbott

TolerRx Announces Manufacturing and Supply Agreement with Abbott
News

TolerRx Announces Manufacturing and Supply Agreement with Abbott

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "TolerRx Announces Manufacturing and Supply Agreement with Abbott"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

TolerRx has announced that it has entered into an agreement with Abbott for the manufacturing of TolerRx's TRX4 monoclonal antibody.

Under the terms of the agreement, Abbott will perform scale-up and GMP manufacturing of TRX4 for use in clinical trials, as well as supply commercial-grade material to support regulatory submissions and potential commercial launch.

"With the recent efficacy data with TRX4 in type 1 diabetes and our ongoing clinical trials in subjects with type 1 diabetes and psoriasis, this agreement positions TolerRx to ensure adequate supply of TRX4 for pivotal clinical studies and, if approved, for commercial sale," stated Douglas J. Ringler, V.M.D., President and CEO of TolerRx.

"In this regard, we are delighted to have Abbott, a company with demonstrated experience and expertise in the manufacturing of monoclonal antibody products, as our manufacturer."

"There is synergy between Abbott's experience, capacity, and technical expertise and TolerRx's manufacturing needs," stated Mark O' Mahony, Director of Process Development, Manufacturing and Quality Control for TolerRx.

"We look forward to working with one of the world's leading health care companies as our manufacturer of TRX4."

Advertisement